Anpario’s (ANP) House Stock Rating Reiterated at Shore Capital Group

Shore Capital Group reaffirmed their house stock rating on shares of Anpario (LON:ANP) in a report published on Monday, Marketbeat.com reports.

Separately, Canaccord Genuity Group reissued a “buy” rating and set a GBX 570 target price on shares of Anpario in a research note on Friday, June 26th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, Anpario currently has an average rating of “Buy” and an average price target of GBX 570.

Anpario Price Performance

Shares of ANP stock opened at GBX 524 on Monday. The company has a quick ratio of 5.16, a current ratio of 4.50 and a debt-to-equity ratio of 0.60. Anpario has a twelve month low of GBX 391.11 and a twelve month high of GBX 580. The company has a market cap of £85.34 million, a P/E ratio of 13.81 and a beta of 1.08. The business has a fifty day simple moving average of GBX 529.35 and a 200 day simple moving average of GBX 520.04.

Anpario declared that its Board of Directors has initiated a stock repurchase program on Monday, April 27th that authorizes the company to buyback 0 shares. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.